<DOC>
	<DOCNO>NCT02801110</DOCNO>
	<brief_summary>Parkinson 's disease ( PD ) chronic , progressive , neurodegenerative disease affect 1 % population old 60 year . The disease present movement disorder manifest mainly rest tremor , bradykinesia , cogwheel rigidity postural instability along cognitive behavioral disturbance symptoms non-motor system dysfunction . The pathophysiology motor dysfunction PD relate gradual loss nigrostriatal dopaminergic neuron ( originate substantia nigra ( SN ) compacta striatum ) lead eventually depletion dopamine striatum . Striatal fluorine-18 isotopologue L-3,4-dihydroxyphenylalanine ( [ 18F ] F-DOPA ) uptake follow typical spatiotemporal pattern along course disease start decreased uptake dorso-caudal putamen ( contralateral side predominant motor involvement ) progress caudate nucleus . The role traditional magnetic resonance imaging ( MRI ) evaluation PD aim mainly differentiate idiopathic PD secondary parkinsonism ( e.g . vascular ) degenerative atypical parkinsonian syndrome ( e.g.Progressive supranuclear palsy ( PSP ) , Multiple system atrophy ( MSA ) etc . ) associate distinct structural feature therefore help establish diagnosis . However , new MR sequence diffuse tensor imaging ( DTI ) susceptibility-weighted imaging ( SWI ) investigate evaluate nigrostriatal dopaminergic neuron iron accumulation SN , respectively . Resting-state functional magnetic resonance imaging ( fMRI ) depict brain network organization show altered patient PD . In technique , temporally synchronous , spatially distribute , spontaneous low frequency blood-oxygen level-dependent signal fluctuation task-free setting cluster map functional large-scale neural network . Lower network efficiency worsen disease progress show patient PD . Recently , show integration MRI PET technically feasible . The investigator believe PET/MRI offer true multimodality image combine anatomy , function molecular process allow accurate identification disease progression . To best knowledge , first study evaluate idiopathic PD ( IPD ) 18F FDOPA PET/MRI . The aim study assess feasibility modality evaluate visually quantitatively association dopamine metabolism measure striatum 18F-FDOPA PET structural functional MR finding patient diagnose IPD asymmetrical motor sign .</brief_summary>
	<brief_title>PET/MR Imaging Patients With Short Long Standing Parkinson 's Disease</brief_title>
	<detailed_description>Study Objectives Purpose : 1 . To assess feasibility 18F FDOPA PET/MR set IPD . 2 . To correlate compare pattern dynamic and/or static 18F-FDOPA uptake striatum MR finding . 3 . To compare different variable contra ipsilateral hemispheric side predominant motor involvement patient asymmetric motor disturbance . Materials Methods : Study Design : This prospective , pilot , cohort Study population : Patients diagnose IPD suffer asymmetrical motor sign . Participant recruitment : Eligible consecutive patient , satisfy inclusion criterion , identify recruited neurological clinic . Informed consent : Before enrollment , write informed consent obtain patient . Participant Sampling : All patient fulfil inclusion criterion provide informed consent consecutively enrol . Imaging diagnostic PET/MR protocol All scan perform department Nuclear Medicine Tel-Aviv Assuta Medical Center use PET/MR scanner ( Biograph mMR , Siemens AG , Erlangen , Germany ) accordance manufacturer 's guideline . Patients require fast least 4 hour prior arrival department . Upon arrival intravenous catheter place radiopharmaceutical gadolinium administration . Patients receive intravenous injection 10 Millicurie ( mCi ) 18F-FDOPA PET MR table scan begin immediately . Dynamic PET parameter acquire along different MR sequence . MR brain include follow sequence : T1 , T2 T2 fluid attenuate inversion recovery sequence ( FLAIR ) , susceptibility-weighted sequence ( SWI ) , blood-oxygenation level-dependent ( BOLD ) signal resting-state functional imaging . In addition , perfusion brain evaluate without gadolinium . For contrast-enhanced sequence investigator use Dotarem ( gadoteric acid ) ( 0.2 ml/kg ,0.1 mmol/kg 2ml/s , 20ml saline flush ) The total scan time 45 minute . Data collection : For eligible patient , follow data record baseline . 1 . Baseline parameter : date birth , sex , age diagnosis ( motor ) symptoms onset . 2 . Detailed medical history . 3 . Physical examination . 4 . List medication ( dos anti PD psychiatric medication ) 5 . Hoehn Yahr stage . 6 . Evaluation use Movement Disorders Society - perform neurologist . MR finding : - Abnormal structural finding brain . - DTI measurement nigrostriatal dopaminergic neuron tract . - Iron overload SN . - Comparison resting-state brain network patient asymmetrical motor sign normal map PET finding : 1 . Visual assessment quantitative measurement static F-DOPA ( e.g. , Standardized Uptake Values ( SUV ) SUVmax SUVmean ) perform putamen caudate nucleus bilaterally . 2 . Measurements dynamic F-DOPA parameter available ( e.g. , time peak , peak value etc . ) measure . Statistics Patient characteristic summarize use descriptive statistic . Quantitative variable present mean SD , qualitative variable present frequency . Pearson correlation coefficient use measure strength relationship PET MR parameter . A t-test used compare mean value different parameter . Sample size : This pilot study sample size 40 patient require .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>1 . Age 30 80 year age . 2 . A clinical diagnosis idiopathic PD . 3 . Patients asymmetric presentation PD ( history/medical documentation ) . 4 . Patients persistent motor asymmetry ( side predominance respect side symptom onset ) . 1 . Patients history brain disorder/pathology . 2 . Patients atypical sign suggest another neurodegenerative disorder , psychiatric disorder , sign severe cognitive deterioration , severe cardiovascular comorbidity 3 . Patients treat levodopa . 4 . Patients medication know interfere DAT catechol Omethyltransferase inhibitor , dopamine receptor block / catecholamine reuptake block property . 5 . Patients suffer dystonia . 6 . Pregnancy/ Breastfeeding . 7 . Contraindication MR imaging . 8 . Uncontrolled head/body movement .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>